The largest database of trusted experimental protocols

Coagpia aptt n

Manufactured by Sekisui
Sourced in Japan, Germany

Coagpia APTT-N is a laboratory equipment used to measure the activated partial thromboplastin time (APTT) in human blood samples. It is designed to assess the intrinsic and common coagulation pathways.

Automatically generated - may contain errors

5 protocols using coagpia aptt n

1

Emergency Department Hemostatic Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood samples were collected at the time of arrival at the ED and before the administration of fluids. Whole blood was collected, with sodium citrate as an anticoagulant, in a conventional blood collection tube (NIPRO, Osaka, Japan). Hemostatic markers were measured within an hour of collection. PT-INR was measured using Thromborel S (Sysmex, Japan) (clotting time method). APTT were measured using Coagpia APTT-N (Sekisui Medical Co, Ltd) (clotting times method). Fibrinogen was measured using Coagpia Fbg (Sekisui Medical Co, Ltd) (thrombin time assay). D-dimer was measured using Factor Auto D-dimer (Q-may Laboratory Co, Ltd) (latex agglutination assay). All parameters were analyzed on automated coagulation analyzer Coapresta 2000 (Sekisui Medical Co, Ltd).
+ Open protocol
+ Expand
2

Activated Partial Thromboplastin Time Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
The activated partial thromboplastin time (APTT) reagent (Coagpia#APTT-N)1 was obtained from SEKISUI MEDICAL CO., LTD., (Tokyo Japan). Recombinant tissue-type plasminogen activator (r-tPA; Activacin®; specific activity 580,000 IU/mg) was purchased from American Diagnostica Inc. (Stamford, CT, USA). Other reagents are identified in relevant parts of the text.
+ Open protocol
+ Expand
3

Comprehensive Blood Biomarker Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood tests included white blood cell (WBC, expressed as /μL, normal range: 3300-8600/μL), hemoglobin (Hb, expressed as g/dL, normal range: 13.7–16.8 g/dL), platelet count (expressed as 104/μL, normal range: 13.1–36.2x104/μL), prothrombin time-international normalized ratio (PT-INR, normal range: 0.90–1.10), activated partial thromboplastin time (APTT, expressed as second (s), normal range: 25.0–40.0 s), fibrinogen (expressed as mg/dL, normal range: 200–400 mg/dL), fibrin degradation products (FDP, expressed as μg/mL, normal range: 0.0–5.0 μg/mL), D-dimer (DD, expressed as μg/mL, normal range: 0.00–1.00 μg/mL) and lactate (expressed as mmol/L, normal range: 0.5–1.6 mmol/L).
WBC, Hb and platelet were measured by the Sysmex XN-9000 (SYSMEX CORPORATION, Kobe, Japan); values of PT-INR, APTT, FDP and DD were obtained by the CP3000 (SEKISUI MEDICAL CO., LTD., Tokyo, Japan); and lactate level was measured by the ABL825 (Radiometer CO., LTD., Tokyo, Japan). The following reagents were used for coagulation tests: PT-INR (Thromborel® S, Siemens Healthcare Diagnostics Products GmbH, Marburg, Germany), APTT (Coagpia® APTT-N, SEKISUI MEDICAL CO., LTD., Tokyo, Japan), fibrinogen (Coagpia® Fbg, SEKISUI MEDICAL CO., LTD., Tokyo, Japan), FDP (Nanopia® P-FDP, SEKISUI MEDICAL CO., LTD., Tokyo, Japan) and DD (Nanopia® D-dimer, SEKISUI MEDICAL CO., LTD., Tokyo, Japan).
+ Open protocol
+ Expand
4

Coagulation Factors Measurement Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
FVIII:C and FIX:C levels were measured using one‐stage clotting assay (HemosIL™ APTT‐SP; Instrumentation Laboratory and Coagpia® APTT‐N; Sekisui Medical Co.) on an ACL 9000 Automated Coagulometer and CP3000™. VWF:Ag levels were measured using latex coagulating nephelometry (STA Listest vWF[FR]; Diagnostica Stago, Inc.) on a JCA‐BM8020 (JEOL).
+ Open protocol
+ Expand
5

Evaluation of APTT Reagent Activators

Check if the same lab product or an alternative is used in the 5 most similar protocols
Two types of APTT reagents; Thrombocheck APTT‐SLA (Sysmex Corporation) and Coagpia APTT‐n (Sekisui Medical Co., Ltd) were used. Table 1 shows activators of the APTT reagents and the phospholipid composition. Fully automated coagulation analyzer CP3000 (Sekisui Medical Co., Ltd.) was used for the measurement of APTT. C‐reactive protein human recombinant (Oriental Yeast Co., Ltd.), human albumin (SIGMA‐ALDRICH), and hexagonal phospholipids (Staclot‐LA; Diagnostica Stago) were used in spiking experiments.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!